The study is a domestic multicenter, prospective, non-randomized controlled concurrent trial. It will be assessed whether surgery staging on locally advanced cervical cancer is superior to image staging for improving progression-free survival and overall survival.
The patients with good compliance, voluntarily signed the informed consent form and participated in the study.
Histopathology: squamous cell carcinoma, adenocarcinoma, adenosquamous cell carcinoma
Stage (FIGO2018): IB3, IIA2, IIB-IVA;
ECOG score: 0 ~ 1;
Activity or uncontrol severe infection;
Liver cirrhosis or other decompensated liver disease;
A history of immune deficiency, including HIV positive or a congenital immunodeficiency disease;
Chronic renal insufficiency or renal failure;